Location History:
- Stockholm-Solna, SE (2013)
- Solna, SE (1999 - 2018)
Company Filing History:
2 out of 3,540 
2 out of 5 
1 out of 1,217 
Years Active: 1999-2018
Title: Gert Auer: Innovator in Cancer Diagnostics
Introduction
Gert Auer is a prominent inventor based in Solna, Sweden, known for his significant contributions to the field of cancer diagnostics. With a total of 7 patents, Auer has focused on developing innovative methods and biomarkers that enhance the diagnosis and treatment of cancer.
Latest Patents
Among his latest patents, Auer has developed a method involving platelet biomarkers in cancer diagnosis. This invention relates to the use of platelet-derived biomarkers for diagnosing cancer or assessing cancer progression, as well as for prognosis and improved treatment strategies. Another notable patent is the gene expression signature of genomic instability in breast cancer. This patent outlines methods for assessing genomic instability in breast cancer tissue by measuring the expression levels of specific genes, providing valuable insights for diagnosis and treatment.
Career Highlights
Throughout his career, Gert Auer has worked with esteemed organizations, including the National Institutes of Health, a component of the US Department of Health & Human Services, and Neodynamics AB. His work in these institutions has allowed him to contribute to groundbreaking research and advancements in cancer diagnostics.
Collaborations
Auer has collaborated with notable colleagues such as Hans Wiksell and Vilhelm Ekstrand, further enhancing the impact of his work in the field.
Conclusion
Gert Auer's innovative contributions to cancer diagnostics through his patents and collaborations highlight his commitment to improving healthcare outcomes. His work continues to influence the landscape of cancer research and treatment.